FDG-PET in patients with painful hip and knee arthroplasty: Technical breakthrough or just more of the same

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 53, Issue 1, 2009, Pages 41-50

  Reinartz, P ^a  

^a Radios Clinic for Radiology and Nuclear Medicine   (Germany)

Author keywords

Arthroplasty; Bone marrow cells; Fluorodeoxyglucose F18; Infection; Inflammation; Leukocytes; Positron emission tomography; Prosthesis implantation

Indexed keywords

ANTIBIOTIC AGENT; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; TECHNETIUM 99M;

ARTICLE; BACTERIUM CULTURE; BONE SCINTISCANNING; CELL LABELING; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DRUG UPTAKE; HIP ARTHROPLASTY; HIP PAIN; HUMAN; KNEE ARTHROPLASTY; LEUKOCYTE; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; REOPERATION; SENSITIVITY AND SPECIFICITY;

ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FLUORODEOXYGLUCOSE F18; HUMANS; LEUKOCYTES; PAIN; POSITRON-EMISSION TOMOGRAPHY;

EID: 65749102230     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Herberts P, Malchau H. Long-term registration has improved the quality of hip replacement: a review of the Swedish THR Register comparing 160,000 cases. Acta Orthop, Scand 2000;71:111-21.
2. Brown SR, Davies WA, DeHeer DH, Swanson AB. Long-term survival of McKee-Farrar total hip prostheses. Clin Orthop 2002;402:157-63.
3. Garellick G, Malchau H, Herberts P. Survival of hip replacements. A comparison of a randomized trial and a registry. Clin Orthop 2000;375:157-67.
4. Furnes O, Lie SA, Espehaug B, Vollset SE, Engesaeter LB, Havelin LI. Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-1999. J Bone Joint Surg Br 2001;83:579-86.
5. Keogh CF, Munk PL, Gee R, Lai PC, Marchinkow LO. Imaging of the painful hip arthroplasty. Am J Roentgenol 2003;180:115-20.
6. Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA et al. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am 2003;85:27-32.
7. Johnson JA, Christie MJ, Sandler MP, Parks PF Jr, Homra L, Kaye JJ. Detection of occult infection following total Joint arthroplasty using sequential technetium-99m HDP bone scintigraphy and indium-111 WBC imaging. J Nucl Med 1988;29:1347-53.
8. Della Valle CJ, Bogner E, Desai P, Lonner JH, Adler E, Zuckerman JD et al. Analysis of frozen sections of intraoperative specimens obtained at the time of reoperation after hip or knee resection arthroplasty for the treatment of infection. J Bone Joint Surg Am 1999;81:684-9.
9. Palestro CJ. Nuclear medicine, the painful prosthetic joint, and orthopedic infection. J Nucl Med 2003;44:927-9.
10. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996;78:512-23.
11. Davis N, Curry A, Gambhir AK, Panigrahi H, Walker CR, Wilkins EG et al. Intraoperative bacterial contamination in operations for joint replacement. J Bone Joint Surg Br 1999;81:886-9.
12. Roder C, Eggli S, Aebi M, Busato A. The validity of clinical examination in the diagnosis of loosening of components in total hip arthroplasty. J Bone Joint Surg Br 2003;85:37-44.
13. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001;21:1229-38.
14. Fitzgerald RH Jr. Diagnosis and management of the infected hip prosthesis. Orthopedics 1995;18:833-5.
15. Barrack RL, Harris WH. The value of aspiration of the hip joint before revision total hip arthroplasty. J Bone Joint Surg Am 1993;75:66-76.
16. Fehring TK, Cohen B. Aspiration as a guide to sepsis in revision total hip arthroplasty. J Arthroplasty 1996;11:543-7.
17. Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone joint Surg Am 1999;81:672-83.
18. Kraemer WJ, Saplys R, Waddell JP, Morton J. Bone scan, gallium scan, and hip aspiration in the diagnosis of infected total hip arthroplasty. J Arthroplasty 1993;8:611-6.
19. Zilkens KW, Wicke A, Zilkens J, Büll U. Nuclear imaging in loosening of hip-joint endoprostheses. Arch Orthop Trauma Surg 1988;107:288-92.
20. Levitsky KA, Hozack WJ, Balderston RA, Rothman RH, Gluckman SJ, Maslack MM et al. Evaluation of the painful prosthetic joint. Relative value of bone scan, sedimentation rate, and joint aspiration. J Arthroplasty 1991;6:237-44.
21. Itasaka T, Kawai A, Sato T, Mitani S, Inoue H. Diagnosis of infection after total hip arthroplasty. J Orthop Sci 2001;6:320-6.
22. El-Maghraby TA, Moustafa HM, Pauwels EK. Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imaging 2006;50:167-92.
23. 99mTc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties. Eur J Nucl Med 2001;28:1496-504.
24. 99mTc-white blood cell and bone imaging improves the diagnostic accuracy in the detection of hip replacement infections. Ent J Nucl Med 2001;28:288-93.
25. Palermo F, Boccaletto F, Paolin A, Carniato A, Zoli P, Giusto F et al. Comparison of technetium-99m-MDP, technetium-99m-WBC and technetium-99m-HIG in musculoskeletal inflammation. J Nucl Med 1998;39:516-21.
26. 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 2001;42:44-8.
27. 18F-FDG-labeled leukocytes. Q J Nucl Med Mol Imaging 2oo6; 50:143-6.
28. 18F]fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun 2002;23:645-53.
29. 18F FDG-PET imaging in musculoskeletal infection. Q J Nucl Med Mol Imaging 2006;50:131-42.
30. Chacko TK, Zhuang H, Stevenson K, Moussavian B, Alavi A. The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl Med Commun 2002;23:851-5.
31. Love C, Pugliese PV, Afriyie MO, Tomas MB, Marwin SE, Palestro CJ. Utility of F-18 FDG imaging for diagnosing the infected joint replacement. Clin Positron Imaging 2000;3:159.
32. Reinartz P, Mumme T, Hermanns B, Cremerius U, Wirtz DC, Schaefer WM et al. Radionuclide imaging of the painful hip arthroplasty: positron emission tomography versus triple-phase bone scan. J Bone joint Surg Br 2005;87:465-70.
33. Blankenberg FG, Strauss HW. Nuclear medicine applications in molecular imaging: 2007 update. Q J Nucl Med Mol Imaging 2007;51:99-110.
34. Benitez A, Roca M, Martin-Comin J. Labeling of antibiotics for infection diagnosis. Q J Nucl Med Mol Imaging 2006;50:147-52.
35. National Center for Biotechnology Information: National Library of Medicine, National Institutes of Health [Internet]. Bethesda, MD, USA: National Center for Biotechnology Information; © 1993-2008 [cited 2008 Dec 12]. Available from: http://www.ncbi.nlm.nih.gov/.
36. Segura AB, Muñoz A, Brulles YR, Hernandez Hermoso JA, Díaz MC, Bajen Lazaro MT et al. What is the role of bone scintigraphy in the diagnosis of infected joint prostheses? Nucl Med Commun 2004;25:527-32.
37. Wilson MA. Musculoskeletal system. In: Wilson MA, editor. Textbook of nuclear medicine. Philadelphia: Lippincott-Raven; 1997.p.3-32.
38. Nagoya S, Kaya M, Sasaki M, Tateda K, Yamashita T. Diagnosis of periprosthetic infection at the hip using triple-phase bone scintigraphy. J Bone joint Surg Br 2008;90:140-4.
39. Hofmann AA, Wyatt RW, Daniels AU, Armstrong L, Alazraki N, Taylor A Jr. Bone scans after total knee arthroplasty in asymptomatic patients. Cemented versus cementless. Clin Orthop Relat Res 1990;251:183-8.
40. Mumme T, Reinartz P, Alfer J, Müller-Rath R, Buell U, Wirtz DC. Diagnostic values of positron emission tomography versus triplephase bone scan in hip arthfoplasty loosening. Arch Orthop Trauma Surg 2005;125:322-9.
41. Stumpe KD, Nötzli HP, Zanetti M, Kamel EM, Harry TF, Görres GW et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 2004;231:333-41.
42. Pfahler M, Schidlo C, Refior HJ. Evaluation of imaging in loosening of hip arthroplasty in 326 consecutive cases. Arch Orthop Trauma Surg. 1998;117:205-7.
43. Lieberman JR, Huo MH, Schneider R, Salvati EA, Rodi S. Evaluation of painful hip arthroplasties. Are technetium bone scans necessary? J Bone Joint Surg Br 1993;75:475-8.
44. Smith SL, Wastie ML, Forster I. Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 2001;56:221-4.
45. Sacchetti GM, Ghisellini F, Brambilla M, De Consoli A, Fornara P, Rizzo E et al. Quantitative scintigraphic evaluation of total knee arthroplasties: a feasibility study. Clin Orthop Relat Res 1996;325:181-9.
46. Verlooy H, Victor J, Renson L, Vandecruys A, Drent P, Mortelmans L et al. Limitations of quantitative radionuclide bone scanning in the evaluation of total knee replacement. Clin Nucl Med 1993;18:671-4.
47. Palestro CJ, Swyer AJ, Kim CK, Goldsmith SJ. Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging. Radiology 1991;179:645-8.
48. Simonsen L, Buhl A, Oersnes T, Duus B. White blood cell scintigraphy for differentiation of infection and aseptic loosening: a retrospective study of 76 painful hip prostheses. Acta Orthop 2007;78:640-7.
49. 18F-labeled fluorodeoxyglucose PET in the management of patients with arthroplasty. Radiol Clin North Am 2007;45:711-8.
50. Pill SG, Parvizi J, Tang PH, Garino JP, Nelson C, Zhuang H et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty 2006;21:91-7.
51. 99mTc white blood cell and three-phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time. Nucl Med Commun 2002;23:655-61.
52. Palestro CJ, Kim CK, Swyer AJ, Capozzi JD, Solomon RW, Goldsmith SJ. Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99msulfur colloid imaging in suspected infection. J Nucl Med 1990;31:1950-5.
53. 99mTc-white blood cell/bone imaging. Nucl Med Commun 2001; 22:1145-50.
54. 99mTc-sulfur colloid marrow imaging. J Nucl Med 2004;45:1864-71.
55. 111In leucocyte scintigraphy in prosthetic joint infection. Nucl Med Commun 2004;25:171-5.
56. 99mTc-HMPAO-leukocyte scintigraphy in patients with symptomatic total hip or knee arthroplasty: improved diagnostic accuracy by means of semiquantitative evaluation. J Nucl Med 2004; 45:438-44.
57. Magnuson JE, Brown ML, Hauser MF, Berquist TH, Fitzgerald RH Jr, Klee GG. In-111-labeled leukocyte scintigraphy in suspected orthopedic prosthesis infection: comparison with other imaging modalities. Radiology 1988;168:235-9.
58. Kälicke T, Schmitz A, Risse JH, Arens S, Keller E, Hansis M et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000;27:524-8.
59. Stumpe KDM, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole body FDG-PET. Eur J Nucl Med 2000;27:822-32.
60. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 2002;21:247-57.
61. DeHeer DH, Engels JA, DeVries AS, Knapp RH, Beebe JD. In situ complement activation by polyethylene wear debris. J Biomed Mater Res 2001;54:12-9.
62. Kadoya Y, Kobayashi A, Ohashi H. Wear and osteolysis in total joint replacements. Acta Orthop Scand Suppl 1998;278:1-16.
63. Schmalzried TP, Jasty M, Rosenberg A, Harris WH. Polyethylene wear debris and tissue reactions in knee as compared to hip replacement prostheses. J Appl Biomater 1994;5:185-90.
64. Oparaugo PC, Clarke IC, Malchau H, Herberts P. Correlation of wear debris-induced osteolysis and revision with volumetric wear-rates of polyethylene: a survey of 8 reports in the literature. Acta Orthop Scand 2001;72:22-8.
65. Orishimo KF, Claus AM, Sychterz CJ, Engh CA. Relationship between polyethylene wear and osteolysis in hips with a second-generation porous-coated cementless cup after seven years of follow-up. J Bone Joint Surg Am 2003;85-A:1095-9.
66. Zhuang H, Chacko TK, Hickeson M, Stevenson K, Feng Q, Ponzo F et al. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty. Eur J Nucl Med Mol Imaging 2002;29:1328-33.
67. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-48.
68. Chryssikos T, Parvizi J, Ghanem E, Newberg A, Zhuang H, Alavi A. FDG-PET imaging can diagnose periprosthetic infection of the hip. Clin Orthop Relat Res 2008;466:1338-42.
69. Vanquickenborne B, Maes A, Nuyts J, Van Acker F, Stuyck J, Mulier M et al. The value of (18)FDG-PET for the detection of infected hip prosthesis. Eur J Nucl Med Mot Imaging 2003;30:705-15.
70. 18F]fluoride positron emission tomography in the early detection of aseptic loosening of total knee arthroplasty. Int J Surg 2007;5:99-104.
71. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
72. Ballinger JR, Gnanasegaran G. Radiolabelled leukocytes for imaging inflammation: how radiochemistry affects clinical use. Q J Nucl Med Mol Imaging 2005;49:308-18.